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ABSTRACT 
 
Trypanosoma cruzi and Trypanosoma brucei are flagellated protozoan parasites that cause Chagas disease and 
African trypanosomiasis in Latin American and African countries, respectively. Currently, over 8 million people are 
infected with T. cruzi and about 25 million more are at risk. About half a million people are affected by T. brucei. 
Trypanosome species share many peculiar biological and biochemical features, such as RNA editing. In contrast, 
they exhibit profound differences at the level of host-parasite interaction and disease pathology. Both parasites are 
transmitted to their host via different insect vectors. There are no available vaccines, and the current treatments have 
severe adverse effects. We were involved in sequencing the T. cruzi genome, an initiative launched by the WHO to 
increase our knowledge of the molecular basis of the parasite. 
 The aim of this thesis was to participate in the sequencing and analysis of the T. cruzi genome, and use the 
data to investigate acetyltransferase enzymes, presumably linked to important metabolic pathways, as possible drug 
targets.  In Papers I and II, we describe genome sequencing and analysis of two distinct T. cruzi strains. One of the 
selected strains, CL Brener, was found to be a genetic hybrid of two divergent strains; and it contains about 22 000 
genes, encoded on 700 scaffolds with a total genome size of 110 Mb. About 50% of the genes are of unknown 
function, and lack homology to other sequenced eukaryotes. Large numbers of members of surface molecule gene 
families, such as trans-sialidase, mucin, mucin-associated protein, and GP63 were found. Comparative analyses 
revealed that TcI had a smaller genome by up to about 11 Mb. The genome size difference was linked to genes 
encoding surface molecules and to other repeats and repeated genes. Additionally, six reading frames present in 
TcVI were not detected in TcI. Genetic polymorphisms such as, indels, microsatellites and SNPs were identified and 
analyzed. Many genes were found to be under different selective pressures in T. cruzi, indicating differential 
evolutionary rates, signifying their importance to parasite biology. Within syntenic regions, the two genomes have 
the same gene complement. Identified features warrant sequencing of further T. cruzi strains, and findings from our 
studies offer opportunities for more targeted functional studies as well as tools for epidemiology. 
  In the second part of this thesis, Papers III to V, a Trypanosoma cruzi acetyltransferase gene family, 
identified in the genome project, was chosen for functional characterization as a first step to evaluate its potential as 
drug target. 
            Acetyltransferases are responsible for protein acetylation, where an acetyl molecule is transferred from 
acetyl-Coenzyme A to lysine residues in a protein sequence, N-epsilon acetylation, and to N-termini of proteins or 
peptides, protein N-alpha acetylation. N-alpha acetylation is linked to many metabolic pathways, influences protein 
stability, protein-protein interaction, localization to organelles and acts as degradation signals. The impact of this 
post-translational modification in parasite is not known.  
We have identified T. cruzi NatC and A, and show that they are expressed in the three life cycle stages 
(epimastigote, trypomastigote, and amastigote). The catalytic and auxiliary subunits form a complex in vivo. 
Additionally, they partially co-sediment with the ribosome and may have both co-translational and post-translational 
protein acetylation functions. In epimastigote, the catalytic subunit of T. cruzi NatA was localized both in the 
nuclear periphery and in cytoplasm, whereas NatC was predominantly assigned to the cytoplasm. The auxiliary 
subunit of NatA was mainly confined to the cytoplasm with cytoskeletal-like labelling, whereas NatC showed a 
punctate profile. Interestingly, the staining patterns of the different subunits analysed for NatA and NatC differ 
between the life cycle stages, which suggests differential regulation and expression.   
  The native substrates for NatC and predicted NatA, are similar to those described in yeast and humans, 
suggesting evolutionary conserved functions. The proteins appear to acetylate a large number of proteins N-
terminally, suggesting that manipulation of the enzymes may simultaneously affect many cellular functions and 
thereby could interfere with or abolish infection. Additionally, our data indicate that NatC and A, may have both N-
alpha and N-epsilon acetylation potential.    
 Collectively, the genome analyses presented here have provided more molecular insights into the parasite's 
biology, and have narrowed the gaps between scientific communities working on parasite research. The 
identification of Nats and native substrates has hopefully laid a solid foundation for future study of Nats, which 
could provide chemotherapeutic targets for parasitic diseases. 
 
 
